Cd26/Dipeptidyl Peptidase IV in Context
Open Access
- 2 August 1999
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 190 (3), 301-306
- https://doi.org/10.1084/jem.190.3.301
Abstract
CD26, the T cell activation molecule, is a 110-kD glycoprotein that is also present on epithelial cells of various tissues, including the liver, kidney, and intestine. CD26 possesses a known dipeptidyl peptidase (DPP)IV activity in its extracellular domain ([1][1]). A paper by Wesley et al. in thisKeywords
This publication has 34 references indexed in Scilit:
- CD13—not just a marker in leukemia typingImmunology Today, 1999
- Negative regulation of the anti‐human immunodeficiency virus and chemotactic activity of human stromal cell‐derived factor 1α by CD26/dipeptidyl peptidase IVFEBS Letters, 1998
- VLA-4-Mediated SignalingPublished by Springer Science and Business Media LLC ,1998
- Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated CleavageThe Journal of Experimental Medicine, 1997
- Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin.Journal of Clinical Pathology, 1994
- Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26Science, 1993
- A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.The Journal of Experimental Medicine, 1993
- Influence of adenosine deaminase inhibition on the phosphoinositide turnover in the initial stages of human T cell activationEuropean Journal of Immunology, 1990
- Direct evidence for the binding of rat liver DPP IV to collagen in vitroExperimental Cell Research, 1988
- The molecular evolution of genes and proteins: a tale of two serinesNature, 1988